NKTR Deadline: Rosen Law Firm Urges Nektar Therapeutics (NASDAQ: NKTR) Stockholders to Contact the Firm for Information About Their RightsApril 27, 2026
Share Twitter Facebook LinkedIn Email Six prominent researchers whose work cast doubt on transgender bans say they are not part of IOC panel determining Olympic participation policy.Read More
NBA Panic Meter Power Rankings: Which teams should be most concerned about the first roundApril 27, 2026